Lumida
/BGM
⌘K
BGM

BGM

BGM
$0.26USD-4.57%-0.01 today

MARKET CAP

110.6M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$12

The case for & against

Bull & Bear analysis

Bearish

BGM Group Ltd. (NASDAQ:BGM) operates at the intersection of healthcare and technology, providing innovative solutions focused primarily on health and wellness products. The company is emerging as a key player within the healthcare technology sector, particularly in developing advanced monitoring systems and solutions aimed at improving health outcomes. With a focus on leveraging technology for better healthcare delivery, BGM is part of the broader theme of digital health transformation and preventative health solutions.

Bull says

  • Analyst EPS forecasts rose sharply, reflecting heightened optimism
  • Liquidity score above 1 indicates capacity to meet near-term obligations
  • Book-to-price ratio at 1.48x suggests potential undervaluation
  • Interest-rate sensitivity implies gains if rates ease
  • Digital health market expansion supports future revenue growth
  • 6% share pullback offers a lower-risk entry point

Bear says

  • Negative earnings yield highlights profitability challenges
  • Leverage metrics point to substantial debt amid rising rates
  • Momentum indicators are down, signaling falling investor sentiment
  • Only one analyst report in past 90 days implies thin coverage
  • 30-for-1 share consolidation underscores capital strain concerns
  • 0.09% dividend yield offers minimal shareholder return